Your Cart Item
Reports Within

Parameters

Reports Within:

Parameter Include:

Requisites
Measures

Number of red blood cells in the blood

Identifies

Red blood cell disorders

Measures: Number of red blood cells in the blood

Identifies: Red blood cell disorders

60
Mins

Homes

1M
Happy

Customers

4.9
Google

Rating

Certified

Labs

What is the maximum days the report can be obtained for the test

The maximum days for obtaining the report for the PDGFRA Gene Analysis Test 3 Exons (12, 14, 18) is 10 days.

What are the prerequisites for the test PDGFRA Gene Analysis Test 3 Exons (12, 14, 18)

  • Requisition form properly filled out
  • Sample type: Whole blood in EDTA tube (lavender top) or extracted DNA
  • Minimum volume: 3 mL whole blood or 5 μg DNA
  • Specimen stability: Whole blood or DNA can be stored at room temperature
  • Shipping: Ship whole blood or DNA at room temperature
  • Turnaround time: 14 days

What are the measure values for the test PDGFRA Gene Analysis Test 3 Exons (12, 14, 18)

  • Exon 12: 0.75 ng/µL
  • Exon 14: 1.02 ng/µL
  • Exon 18: 0.88 ng/µL

What does this test PDGFRA Gene Analysis Test 3 Exons (12, 14, 18) identify?

  • This test identifies mutations in the PDGFRA gene in Exons 12, 14, and 18.
  • PDGFRA gene encodes a receptor tyrosine kinase that plays a role in cell growth and division.
  • Mutations in the PDGFRA gene have been associated with various types of cancer, including gastrointestinal stromal tumors (GISTs).
  • Identifying mutations in these specific exons can help in the diagnosis and treatment of patients with GISTs.

Why is this test PDGFRA Gene Analysis Test 3 Exons (12, 14, 18) taken?

The PDGFRA Gene Analysis Test 3 Exons (12, 14, 18) is taken to detect any mutations or abnormalities in the PDGFRA gene. This gene provides instructions for making a protein that plays a key role in cell growth and division. Mutations in the PDGFRA gene can lead to uncontrolled cell growth and division, which can contribute to the development of certain types of cancer.

By analyzing specific exons (12, 14, 18) of the PDGFRA gene, healthcare providers can identify any genetic changes that may be present and assess the risk of developing cancer or other related conditions. This information can help in early detection, treatment planning, and monitoring of the disease.

No FAQs available.

Customer Google Rating